Exercise Prehabilitation for Locoregional Esophageal Cancer

Description

The purpose of the study is to examine the feasibility and acceptability of exercise "prehabilitation" for patients preparing for esophageal cancer resection (removal).

Conditions

Esophageal Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the study is to examine the feasibility and acceptability of exercise "prehabilitation" for patients preparing for esophageal cancer resection (removal).

Exercise Prehabilitation for Locoregional Esophageal Cancer: A Pilot Study

Exercise Prehabilitation for Locoregional Esophageal Cancer

Condition
Esophageal Cancer
Intervention / Treatment

-

Contacts and Locations

Tampa

Moffitt Cancer Center, Tampa, Florida, United States, 33612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Biopsy-proven locoregional esophageal cancer (LEC)
  • * Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • * Treatment plan including neoadjuvant chemoradiation therapy and surgical resection
  • * Ability to read and speak English
  • * Regular engagement in resistance training (2x/week targeting all major muscle groups)
  • * Screen failure for exercise safety based on PAR-Q
  • * Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
  • * Recent fracture or acute musculoskeletal injury that precludes ability to participate in resistance training safely
  • * Numeric pain rating scale of 7 or more out of 10
  • * Myopathic or rheumatologic disease that impacts physical function

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

H. Lee Moffitt Cancer Center and Research Institute,

Nathan Parker, PhD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

2027-05